UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003521 |
|---|---|
| Receipt number | R000004274 |
| Scientific Title | Randomized Phase II clinical trial of personalized peptide vaccination for patients with advanced (stage IIIB/IV) or recurrence non-small cell lung cancer who had chemotheraphy of 1 or 2 regimen, to evaluate the progression free survial of docetaxel plus placebo versus docetaxel plus pesonalized pepitide vaccine. |
| Date of disclosure of the study information | 2010/04/22 |
| Last modified on | 2015/04/22 10:55:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/22 14:52:43 | ||
| 2 | Update | 2010/07/16 14:38:49 | Organization1 Address1 Tel1 Email1 |
|
| 3 | Update | 2010/08/03 12:40:51 | Key inclusion criteria |
|
| 4 | Update | 2011/10/28 11:52:55 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 5 | Update | 2011/10/28 11:53:30 | Key inclusion criteria Key inclusion criteria |
|
| 6 | Update | 2013/11/28 13:23:38 | Recruitment status |
|
| 7 | Update | 2015/04/22 10:55:52 | Recruitment status |
